Hemorrhagic stroke, characterized by the rupture of a blood vessel in the brain, remains one of the most debilitating medical conditions worldwide. Unlike ischemic strokes, hemorrhagic events often result in higher mortality and more profound functional deficits. However, the global landscape of Hemorrhagic Stroke Rehabilitation is undergoing a paradigm shift. Historically, treatment focused on immediate survival; today, the emphasis has moved toward intensive, technology-driven functional recovery.
In developed regions like North America and Europe, there is an increasing demand for robotic-assisted therapies and neuroplasticity-focused interventions. Meanwhile, in emerging markets, the focus is on expanding access to specialized rehabilitation centers. As a leading manufacturer, we recognize that the "one-size-fits-all" approach is obsolete. Modern rehabilitation requires a synergy between clinical expertise and advanced biomechanical engineering.
The global neuro-rehabilitation market is projected to reach billions by 2030, driven by an aging population and higher survival rates post-stroke.
International clinical guidelines now mandate early intervention using objective evaluation tools like 3D gait analysis and isokinetic testing.
Advanced feedback systems increase patient motivation by 40%, significantly shortening the total rehabilitation cycle.
ISO and CE certifications are becoming non-negotiable for global procurement, ensuring safety in high-intensity neuro-training.
Distributors and hospital chains in the Middle East, Southeast Asia, and South America are increasingly looking for high-quality, cost-effective manufacturers who can provide full-cycle solutions. Their primary needs include:
Leading the Future of Rehabilitation Medicine
With 30 years of industrial experience and 15 years dedicated specifically to rehabilitation R&D, Xinkang is a titan in the medical device sector. We operate as a full-cycle manufacturer, integrating research, production, and sales to provide a closed-loop service for our global partners. Our focus spans pain management, orthopedic rehabilitation, and most critically, neurological rehabilitation for stroke survivors.
Professional Expertise: We are domestic leaders in physical factor treatment, specializing in electrotherapy, light therapy, and magnetic therapy. In China, our equipment is present in over 75% of tertiary medical units.
Years Experience
OEM Customers
Sqm Factory Area
Hospital Coverage
Our team comprises engineers from top-tier universities. We don't just assemble; we innovate. Our software and hardware are 100% independently developed, ensuring easy localization and rapid updates.
Located in the heart of China’s supply chain (Changshanjiao), our 10,000sqm facility houses 30+ standard production lines. This proximity ensures cost-efficiency and unmatched speed-to-market.
We adhere to international quality benchmarks. With 1 invention patent, 7 utility model patents, and 13 software copyrights, our intellectual property portfolio reflects our commitment to reliability.
From OEM assembly guidance to professional clinical training and sales courses, we empower our partners to not just buy equipment, but to build successful rehabilitation brands.
MedTrack
